Agency Forms Undergoing Paperwork Reduction Act Review, 66965-66966 [2016-23506]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 189 / Thursday, September 29, 2016 / Notices
Board of Governors of the Federal Reserve
System, September 26, 2016.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2016–23549 Filed 9–28–16; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[30Day–16–0852]
mstockstill on DSK3G9T082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
18:51 Sep 28, 2016
Jkt 238001
Prevalence Survey of HealthcareAssociated Infections (HAIs) and
Antimicrobial Use in U.S. Acute Care
Hospitals—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Centers for Disease Control and
Prevention
VerDate Sep<11>2014
Proposed Project
Preventing healthcare-associated
infections (HAIs) and reducing the
emergence and spread of antimicrobial
resistance are priorities for the CDC and
the U.S. Department of Health and
Human Services (DHHS). Improving
antimicrobial drug prescribing in the
United States is a critical component of
strategies to reduce antimicrobial
resistance, and is a key component of
the President’s National Strategy for
Combating Antibiotic Resistant Bacteria
(CARB), which calls for ‘‘inappropriate
inpatient antibiotic use for monitored
conditions/agents’’ to be ‘‘reduced 20%
from 2014 levels’’ (page 9, https://
www.whitehouse.gov/sites/default/files/
docs/carb_national_strategy.pdf). To
achieve these goals and improve patient
safety in the United States, it is
necessary to know the current burden of
infections and antimicrobial drug use in
different healthcare settings, including
the types of infections and drugs used
in short-term acute care hospitals, the
pathogens causing infections, and the
quality of antimicrobial drug
prescribing.
Today more than 5,000 short-term
acute care hospitals participate in
national HAI surveillance through the
CDC’s National Healthcare Safety
Network (NHSN, OMB Control No.
0920–0666, expiration 12/31/18). These
hospitals’ surveillance efforts are
focused on those HAIs that are required
to be reported as part of state legislative
mandates or Centers for Medicare &
Medicaid Services (CMS) Inpatient
Quality Reporting (IQR) Program.
Hospitals do not report data on all types
of HAIs occurring hospital-wide. Data
from a previous prevalence survey
showed that approximately 28% of all
HAIs are included in the CMS IQR
Program. Periodic assessments of the
magnitude and types of HAIs occurring
in all patient populations in hospitals
are needed to inform decisions by local
and national policy makers and by
hospital infection prevention
professionals regarding appropriate
targets and strategies for HAI
prevention.
The CDC’s hospital prevalence survey
efforts began in 2008–2009. A pilot
survey was conducted over a 1-day
period at each of nine acute care
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
66965
hospitals in one U.S. city. This pilot
phase was followed in 2010 by a phase
2, limited roll-out HAI and
antimicrobial use prevalence survey,
conducted in 22 hospitals across 10
Emerging Infections Program sites
(California, Colorado, Connecticut,
Georgia, Maryland, Minnesota, New
Mexico, New York, Oregon, and
Tennessee). A full-scale, phase 3 survey
was conducted in 2011, involving 183
hospitals in the 10 Emerging Infections
Program (EIP) sites. Data from this
survey conducted in 2011 showed that
there were an estimated 722,000 HAIs in
U.S acute care hospitals in 2011, and
about half of the 11,282 patients
included in the survey in 2011 were
receiving antimicrobial drugs. The
survey was repeated in 2015–2016 to
update the national HAI and
antimicrobial drug use burden; data
from this survey will also provide
baseline information on the quality of
antimicrobial drug prescribing for
selected, common clinical conditions in
hospitals. Data collection is ongoing at
this time.
A revision of the prevalence survey’s
existing OMB approval is sought to
reduce the data collection burden and to
extend the approval to allow another
short-term acute care hospital survey to
be conducted in 2019. Data from the
2019 survey will be used to evaluate
progress in eliminating HAIs and
improving antimicrobial drug use.
The 2019 survey will be performed in
a sample of up to 300 acute care
hospitals, drawn from the acute care
hospital populations in each of the 10
EIP sites (and including participation
from many hospitals that participated in
prior phases of the survey). Infection
prevention personnel in participating
hospitals and EIP site personnel will
collect demographic and clinical data
from the medical records of a sample of
eligible patients in their hospitals on a
single day in 2019, to identify CDCdefined HAIs and collect information on
antimicrobial drug use. The survey data
will be used to estimate the prevalence
of HAIs and antimicrobial drug use and
describe the distribution of infection
types and pathogens. The data will also
be used to determine the quality of
antimicrobial drug prescribing. These
data will inform strategies to reduce and
eliminate healthcare-associated
infections—a DHHS Healthy People
2020 objective (https://
www.healthypeople.gov/2020/
topicsobjectives2020/
overview.aspx?topicid=17). This survey
project also supports the CDC Winnable
Battle goal of improving national
surveillance for healthcare-associated
infections (https://www.cdc.gov/
E:\FR\FM\29SEN1.SGM
29SEN1
66966
Federal Register / Vol. 81, No. 189 / Thursday, September 29, 2016 / Notices
winnablebattles/Goals.html) and the
CARB National Strategy (https://
www.whitehouse.gov/sites/default/files/
docs/carb_national_strategy.pdf) and
Action Plan (https://
www.whitehouse.gov/sites/default/files/
docs/national_action_plan_for_
combating_antibotic-resistant_
bacteria.pdf).
There are no costs to the respondents
other than their time. The total
estimated annual burden hours is 1,860.
This represents a reduction in the total
estimated annual burden hours from the
previous approval due to a reduction in
the number of respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Infection preventionist .....................................
Infection preventionist .....................................
Healthcare Facility Assessment (HFA) ..........
Patient Information Form (PIF) ......................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23506 Filed 9–28–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–297 (CMS–
L564)]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; the accuracy of
the estimated burden; ways to enhance
the quality, utility, and clarity of the
information to be collected; and the use
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:51 Sep 28, 2016
Jkt 238001
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by October 31, 2016.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
PO 00000
Frm 00048
Fmt 4703
Sfmt 9990
Number of
responses per
respondent
100
100
Average
burden per
response
(in hrs.)
1
63
45/60
17/60
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Request for
Employment Information; Use: Section
1837(i) of the Social Security Act
provides for a special enrollment period
for individuals who delay enrolling in
Medicare Part B because they are
covered by a group health plan based on
their own or a spouse’s current
employment status. Disabled
individuals with Medicare may also
delay enrollment because they have
large group health plan coverage based
on their own or a family member’s
current employment status. When these
individuals apply for Medicare Part B,
they must provide proof that the group
health plan coverage is (or was) based
on current employment status. Form
Number: CMS–R–297 (CMS–L564)
(OMB control number: 0938–0787);
Frequency: Once; Affected Public:
Private sector (Business or other forprofits and Not-for-profit institutions);
Number of Respondents: 15,000; Total
Annual Responses: 15,000; Total
Annual Hours: 5,000. (For policy
questions regarding this collection
contact Lindsay Scully at 410–786–
6843.)
Dated: September 26, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2016–23537 Filed 9–28–16; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 81, Number 189 (Thursday, September 29, 2016)]
[Notices]
[Pages 66965-66966]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23506]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0852]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Prevalence Survey of Healthcare-Associated Infections (HAIs) and
Antimicrobial Use in U.S. Acute Care Hospitals--Revision--National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated infections (HAIs) and reducing the
emergence and spread of antimicrobial resistance are priorities for the
CDC and the U.S. Department of Health and Human Services (DHHS).
Improving antimicrobial drug prescribing in the United States is a
critical component of strategies to reduce antimicrobial resistance,
and is a key component of the President's National Strategy for
Combating Antibiotic Resistant Bacteria (CARB), which calls for
``inappropriate inpatient antibiotic use for monitored conditions/
agents'' to be ``reduced 20% from 2014 levels'' (page 9, https://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf). To achieve these goals and improve patient
safety in the United States, it is necessary to know the current burden
of infections and antimicrobial drug use in different healthcare
settings, including the types of infections and drugs used in short-
term acute care hospitals, the pathogens causing infections, and the
quality of antimicrobial drug prescribing.
Today more than 5,000 short-term acute care hospitals participate
in national HAI surveillance through the CDC's National Healthcare
Safety Network (NHSN, OMB Control No. 0920-0666, expiration 12/31/18).
These hospitals' surveillance efforts are focused on those HAIs that
are required to be reported as part of state legislative mandates or
Centers for Medicare & Medicaid Services (CMS) Inpatient Quality
Reporting (IQR) Program. Hospitals do not report data on all types of
HAIs occurring hospital-wide. Data from a previous prevalence survey
showed that approximately 28% of all HAIs are included in the CMS IQR
Program. Periodic assessments of the magnitude and types of HAIs
occurring in all patient populations in hospitals are needed to inform
decisions by local and national policy makers and by hospital infection
prevention professionals regarding appropriate targets and strategies
for HAI prevention.
The CDC's hospital prevalence survey efforts began in 2008-2009. A
pilot survey was conducted over a 1-day period at each of nine acute
care hospitals in one U.S. city. This pilot phase was followed in 2010
by a phase 2, limited roll-out HAI and antimicrobial use prevalence
survey, conducted in 22 hospitals across 10 Emerging Infections Program
sites (California, Colorado, Connecticut, Georgia, Maryland, Minnesota,
New Mexico, New York, Oregon, and Tennessee). A full-scale, phase 3
survey was conducted in 2011, involving 183 hospitals in the 10
Emerging Infections Program (EIP) sites. Data from this survey
conducted in 2011 showed that there were an estimated 722,000 HAIs in
U.S acute care hospitals in 2011, and about half of the 11,282 patients
included in the survey in 2011 were receiving antimicrobial drugs. The
survey was repeated in 2015-2016 to update the national HAI and
antimicrobial drug use burden; data from this survey will also provide
baseline information on the quality of antimicrobial drug prescribing
for selected, common clinical conditions in hospitals. Data collection
is ongoing at this time.
A revision of the prevalence survey's existing OMB approval is
sought to reduce the data collection burden and to extend the approval
to allow another short-term acute care hospital survey to be conducted
in 2019. Data from the 2019 survey will be used to evaluate progress in
eliminating HAIs and improving antimicrobial drug use.
The 2019 survey will be performed in a sample of up to 300 acute
care hospitals, drawn from the acute care hospital populations in each
of the 10 EIP sites (and including participation from many hospitals
that participated in prior phases of the survey). Infection prevention
personnel in participating hospitals and EIP site personnel will
collect demographic and clinical data from the medical records of a
sample of eligible patients in their hospitals on a single day in 2019,
to identify CDC-defined HAIs and collect information on antimicrobial
drug use. The survey data will be used to estimate the prevalence of
HAIs and antimicrobial drug use and describe the distribution of
infection types and pathogens. The data will also be used to determine
the quality of antimicrobial drug prescribing. These data will inform
strategies to reduce and eliminate healthcare-associated infections--a
DHHS Healthy People 2020 objective (https://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=17). This survey project
also supports the CDC Winnable Battle goal of improving national
surveillance for healthcare-associated infections (https://www.cdc.gov/
[[Page 66966]]
winnablebattles/Goals.html) and the CARB National Strategy (https://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf)
and Action Plan (https://www.whitehouse.gov/sites/default/files/docs/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf).
There are no costs to the respondents other than their time. The
total estimated annual burden hours is 1,860. This represents a
reduction in the total estimated annual burden hours from the previous
approval due to a reduction in the number of respondents.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Infection preventionist............... Healthcare Facility 100 1 45/60
Assessment (HFA).
Infection preventionist............... Patient Information Form 100 63 17/60
(PIF).
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-23506 Filed 9-28-16; 8:45 am]
BILLING CODE 4163-18-P
